Abbott’s ID NOW COVID-19 rapid test shows strong agreement to PCR instruments
Interim clinical study data shows ID NOW test performance of 94.7% sensitivity and 98.6% specificity
Interim clinical study data shows ID NOW test performance of 94.7% sensitivity and 98.6% specificity
Driven by the gap in COVID-19 testing, the collaboration aims to create a fully disposable, rapid and handheld test for consumers
A qualitative test for the detection of nucleic acid from SARS-CoV-2
Study suggests that type I IFN deficiency in the blood could help define a high-risk population
The COVID-19 vaccine trial is part of a global development program that will uncover the safety and immunogenicity of four mRNA vaccine candidates.
Test deployed on Quanterix' Simoa platform promises 1,000-fold sensitivity improvement
Science industry comes together online to share knowledge and provide technology solutions for cancer and immunology research
Assay will help guide treatment decisions in cases of non-small cell lung cancer
The company says it continues to optimize its coronavirus test amid questions about its accuracy
Collaboration with WuXi Diagnostics and Mayo Clinic on serology test will complement Thermo Fisher's widely adopted TaqPath COVID-19 molecular diagnostic test
The digital tool could help simplify the screening, diagnosis and monitoring of patients with respiratory compromise in the current COVID-19 pandemic
The Alinity m molecular laboratory COVID-19 test instrument claims it can run up to 1,080 tests in 24 hours
The U.S. Food and Drug Administration has authorized the first coronavirus test using at-home collection of saliva samples
Partnership to broaden the availability of COVID-19 antibody testing with 100% specificity
The real-time PCR system aims to accelerate coronavirus research and diagnostics
Clinical laboratories certified to perform high complexity tests under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this ELISA
Register today to reserve a place at the Summit - it opens at 13:00 (BST) / 14:00 (CEST) / 08:00 (EDT) / 05:00 (PDT) on Monday, May 11